{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:59:06Z","timestamp":1787317146071,"version":"build-2736575974"},"reference-count":215,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"am","delay-in-days":352,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570469"],"award-info":[{"award-number":["81570469"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81620108002"],"award-info":[{"award-number":["81620108002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771732"],"award-info":[{"award-number":["81771732"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81830016"],"award-info":[{"award-number":["81830016"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81922010,81873561"],"award-info":[{"award-number":["81922010,81873561"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.cld.2022.06.003","type":"journal-article","created":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T01:29:03Z","timestamp":1663118943000},"page":"583-611","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Immunologic Responses and the Pathophysiology of Primary Biliary Cholangitis"],"prefix":"10.1016","volume":"26","author":[{"given":"Ruiling","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruqi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Eric","family":"Gershwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cld.2022.06.003_bib1","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","article-title":"Primary biliary cirrhosis","volume":"353","author":"Kaplan","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2022.06.003_bib2","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/S0140-6736(10)61965-4","article-title":"Primary biliary cirrhosis","volume":"377","author":"Selmi","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2022.06.003_bib3","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(20)31607-X","article-title":"Primary biliary cholangitis","volume":"396","author":"Lleo","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2022.06.003_bib4","doi-asserted-by":"crossref","first-page":"102328","DOI":"10.1016\/j.jaut.2019.102328","article-title":"The challenges of primary biliary cholangitis: what is new and what needs to be done","volume":"105","author":"Terziroli Beretta-Piccoli","year":"2019","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.cld.2022.06.003_bib5","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.jhep.2015.06.031","article-title":"Changing nomenclature for PBC: from 'cirrhosis' to 'cholangitis","volume":"63","author":"Beuers","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2022.06.003_bib6","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.cgh.2020.06.025","article-title":"Effects of primary biliary cholangitis on Quality of Life and Health Care Costs in the United Kingdom","volume":"19","author":"Rice","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2022.06.003_bib7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"Electronic address eee and European Association for the Study of the L. EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis","volume":"67","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2022.06.003_bib8","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/hep.30145","article-title":"Primary biliary cholangitis: 2018 Practice Guidance from the American association for the study of liver diseases","volume":"69","author":"Lindor","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib9","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jhep.2020.05.041","article-title":"Primary biliary cholangitis: a multifaceted pathogenesis with potential therapeutic targets","volume":"73","author":"Carbone","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2022.06.003_bib10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev-publhealth-040617-014629","article-title":"Environmental influences on the Epigenome: exposure- associated DNA methylation in human Populations","volume":"39","author":"Martin","year":"2018","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.cld.2022.06.003_bib11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s40168-020-00923-9","article-title":"The interplay between host genetics and the gut microbiome reveals common and distinct microbiome features for complex human diseases","volume":"8","author":"Xu","year":"2020","journal-title":"Microbiome"},{"key":"10.1016\/j.cld.2022.06.003_bib12","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.clinre.2016.05.011","article-title":"The epigenetics of PBC: the link between genetic susceptibility and environment","volume":"40","author":"Marzorati","year":"2016","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.cld.2022.06.003_bib13","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/cmi.2017.137","article-title":"Genetic and epigenetic influences on the loss of tolerance in autoimmunity","volume":"15","author":"Zhang","year":"2018","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.cld.2022.06.003_bib14","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(65)91372-3","article-title":"Serological tests in diagnosis of primary biliary cirrhosis","volume":"1","author":"Walker","year":"1965","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2022.06.003_bib15","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.4049\/jimmunol.138.10.3525","article-title":"Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis","volume":"138","author":"Gershwin","year":"1987","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.cld.2022.06.003_bib16","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0140-6736(88)91894-6","article-title":"Primary biliary cirrhosis: identification of two major M2 mitochondrial autoantigens","volume":"1","author":"Yeaman","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2022.06.003_bib17","doi-asserted-by":"crossref","first-page":"7317","DOI":"10.1073\/pnas.85.19.7317","article-title":"Primary structure of the human M2 mitochondrial autoantigen of primary biliary cirrhosis: dihydrolipoamide acetyltransferase","volume":"85","author":"Coppel","year":"1988","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.cld.2022.06.003_bib18","doi-asserted-by":"crossref","first-page":"8654","DOI":"10.1073\/pnas.85.22.8654","article-title":"Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis","volume":"85","author":"Fussey","year":"1988","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.cld.2022.06.003_bib19","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1053\/j.gastro.2003.09.034","article-title":"Autoreactivity to lipoate and a conjugated form of lipoate in primary biliary cirrhosis","volume":"125","author":"Bruggraber","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2022.06.003_bib20","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/hep.20491","article-title":"Sidechain biology and the immunogenicity of PDC-E2, the major autoantigen of primary biliary cirrhosis","volume":"40","author":"Mao","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib21","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1172\/JCI4213","article-title":"Identification and precursor frequency analysis of a common T\u00a0cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis","volume":"102","author":"Shimoda","year":"1998","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cld.2022.06.003_bib22","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1172\/JCI0214698","article-title":"Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis","volume":"109","author":"Kita","year":"2002","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cld.2022.06.003_bib23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1084\/jem.20010956","article-title":"Identification of HLA-A2-restricted CD8(+) cytotoxic T\u00a0cell responses in primary biliary cirrhosis: T\u00a0cell activation is augmented by immune complexes cross-presented by dendritic cells","volume":"195","author":"Kita","year":"2002","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.cld.2022.06.003_bib24","doi-asserted-by":"crossref","first-page":"111754","DOI":"10.1016\/j.biopha.2021.111754","article-title":"The pathogenesis, models and therapeutic advances of primary biliary cholangitis","volume":"140","author":"Li","year":"2021","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"10.1016\/j.cld.2022.06.003_bib25","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s43440-021-00351-y","article-title":"Selected transgenic murine models of human autoimmune liver diseases","volume":"74","author":"Trzos","year":"2022","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.cld.2022.06.003_bib26","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.4049\/jimmunol.177.3.1655","article-title":"Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice","volume":"177","author":"Oertelt","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.cld.2022.06.003_bib27","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/hep.22052","article-title":"Natural killer T\u00a0cells exacerbate liver injury in a transforming growth factor beta receptor II dominant-negative mouse model of primary biliary cirrhosis","volume":"47","author":"Chuang","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib28","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1002\/hep.22226","article-title":"Adoptive transfer of CD8(+) T\u00a0cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice","volume":"47","author":"Yang","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib29","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/hep.23238","article-title":"B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-beta receptor II dominant negative mice","volume":"50","author":"Moritoki","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib30","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/hep.23783","article-title":"Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis","volume":"52","author":"Lleo","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib31","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.3748\/wjg.14.3374","article-title":"Autoimmune liver serology: current diagnostic and clinical challenges","volume":"14","author":"Bogdanos","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cld.2022.06.003_bib32","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/apt.16023","article-title":"Review article: pathophysiology and management of primary biliary cholangitis","volume":"52","author":"Leung","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2022.06.003_bib33","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1568-9972(03)00013-2","article-title":"Antinuclear antibodies specific for primary biliary cirrhosis","volume":"2","author":"Worman","year":"2003","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.cld.2022.06.003_bib34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3233\/HAB-1996-7404","article-title":"Anti-gp210 antibodies in sera of patients with primary biliary cirrhosis. Identification of a 64 kD fragment of gp210 as a major epitope","volume":"7","author":"Wesierska-Gadek","year":"1996","journal-title":"Hum Antibodies Hybridomas"},{"key":"10.1016\/j.cld.2022.06.003_bib35","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1055\/s-2007-1007185","article-title":"Nuclear envelope protein autoantibodies in primary biliary cirrhosis","volume":"17","author":"Courvalin","year":"1997","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cld.2022.06.003_bib36","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1055\/s-2007-1007184","article-title":"Autoantibodies against \"nuclear dots\" in primary biliary cirrhosis","volume":"17","author":"Szostecki","year":"1997","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cld.2022.06.003_bib37","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/ajg.2009.596","article-title":"PML nuclear body component Sp140 is a novel autoantigen in primary biliary cirrhosis","volume":"105","author":"Granito","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2022.06.003_bib38","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jaut.2005.10.007","article-title":"Increased expression of nuclear envelope gp210 antigen in small bile ducts in primary biliary cirrhosis","volume":"26","author":"Nakamura","year":"2006","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.cld.2022.06.003_bib39","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1440-1746.1995.tb01597.x","article-title":"High prevalence of antibodies to recombinant CENP-B in primary biliary cirrhosis: nuclear immunofluorescence patterns and ELISA reactivities","volume":"10","author":"Parveen","year":"1995","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2022.06.003_bib40","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/hep.21472","article-title":"Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis","volume":"45","author":"Nakamura","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib41","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1053\/jhep.2002.33541","article-title":"The pathobiology of biliary epithelia","volume":"35","author":"Alpini","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib42","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1046\/j.1440-1746.2000.02091.x","article-title":"Pathophysiology of the intrahepatic biliary epithelium","volume":"15","author":"Strazzabosco","year":"2000","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2022.06.003_bib43","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/S0016-5085(96)70027-6","article-title":"Regrowth of the rat biliary tree after 70% partial hepatectomy is coupled to increased secretin-induced ductal secretion","volume":"111","author":"Lesage","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2022.06.003_bib44","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1053\/j.gastro.2004.08.006","article-title":"The cholangiopathies: disorders of biliary epithelia","volume":"127","author":"Lazaridis","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2022.06.003_bib45","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jaut.2008.04.009","article-title":"The consequences of apoptosis in autoimmunity","volume":"31","author":"Lleo","year":"2008","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.cld.2022.06.003_bib46","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.22736","article-title":"Apotopes and the biliary specificity of primary biliary cirrhosis","volume":"49","author":"Lleo","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib47","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/hep.24355","article-title":"Epithelial cell specificity and apotope recognition by serum autoantibodies in primary biliary cirrhosis","volume":"54","author":"Rong","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib48","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/hep.510250505","article-title":"Nuclear DNA fragmentation and expression of Bcl-2 in primary biliary cirrhosis","volume":"25","author":"Koga","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib49","doi-asserted-by":"crossref","first-page":"10895","DOI":"10.1073\/pnas.0802702105","article-title":"Death receptor 5 mediated-apoptosis contributes to cholestatic liver disease","volume":"105","author":"Takeda","year":"2008","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.cld.2022.06.003_bib50","first-page":"1031","article-title":"Abnormal expression of the E2 component of the pyruvate dehydrogenase complex on the luminal surface of biliary epithelium occurs before major histocompatibility complex class II and BB1\/B7 expression","volume":"21","author":"Tsuneyama","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib51","first-page":"1440","article-title":"Abnormal expression of PDC-E2 on the apical surface of biliary epithelial cells in patients with antimitochondrial antibody-negative primary biliary cirrhosis","volume":"22","author":"Tsuneyama","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib52","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/hep.31067","article-title":"The Spectrum of reactive cholangiocytes in primary sclerosing cholangitis","volume":"71","author":"Guicciardi","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib53","article-title":"Cellular senescence in the cholangiopathies: a driver of immunopathology and a novel therapeutic target","author":"Trussoni","year":"2022","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.cld.2022.06.003_bib54","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/MOG.0000000000000805","article-title":"Cellular senescence in the cholangiopathies","volume":"38","author":"Bogert","year":"2022","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.cld.2022.06.003_bib55","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/hep.22348","article-title":"Telomere shortening in the damaged small bile ducts in primary biliary cirrhosis reflects ongoing cellular senescence","volume":"48","author":"Sasaki","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib56","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jhep.2010.03.008","article-title":"Modulation of the microenvironment by senescent biliary epithelial cells may be involved in the pathogenesis of primary biliary cirrhosis","volume":"53","author":"Sasaki","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2022.06.003_bib57","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/hep.22102","article-title":"Biliary epithelial cells and primary biliary cirrhosis: the role of liver-infiltrating mononuclear cells","volume":"47","author":"Shimoda","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib58","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hep.23318","article-title":"CX3CL1 (fractalkine): a signpost for biliary inflammation in primary biliary cirrhosis","volume":"51","author":"Shimoda","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib59","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/hep.20582","article-title":"Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts","volume":"41","author":"Isse","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib60","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.jhep.2012.07.008","article-title":"CXCR3-dependent recruitment and CCR6-mediated positioning of Th-17 cells in the inflamed liver","volume":"57","author":"Oo","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2022.06.003_bib61","doi-asserted-by":"crossref","first-page":"8019","DOI":"10.1038\/ncomms9019","article-title":"International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways","volume":"6","author":"Cordell","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.cld.2022.06.003_bib62","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00281-009-0172-5","article-title":"The immunopathology of human biliary cell epithelium","volume":"31","author":"Chuang","year":"2009","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.cld.2022.06.003_bib63","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jaut.2016.08.006","article-title":"Hydrophobic bile acids suppress expression of AE2 in biliary epithelial cells and induce bile duct inflammation in primary biliary cholangitis","volume":"75","author":"Hisamoto","year":"2016","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.cld.2022.06.003_bib64","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.gastro.2003.07.013","article-title":"Distinct costimulation dependent and independent autoreactive T-cell clones in primary biliary cirrhosis","volume":"125","author":"Kamihira","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2022.06.003_bib65","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/hep.20494","article-title":"Biliary epithelial cells regulate autoreactive T\u00a0cells: implications for biliary-specific diseases","volume":"41","author":"Kamihira","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib66","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/nri957","article-title":"A\u00a0blast from the past: clearance of apoptotic cells regulates immune responses","volume":"2","author":"Savill","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cld.2022.06.003_bib67","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/hep.27840","article-title":"The biliary epithelium presents antigens to and activates natural killer T\u00a0cells","volume":"62","author":"Schrumpf","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib68","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.jhep.2015.12.017","article-title":"Biliary epithelium and liver B cells exposed to bacteria activate intrahepatic MAIT cells through MR1","volume":"64","author":"Jeffery","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2022.06.003_bib69","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.mayocp.2015.03.017","article-title":"The cholangiopathies","volume":"90","author":"Lazaridis","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cld.2022.06.003_bib70","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.24691","article-title":"A\u00a0biliary HCO3- umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes","volume":"55","author":"Hohenester","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib71","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/hep.25691","article-title":"Up-regulation of microRNA 506 leads to decreased Cl-\/HCO3- anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis","volume":"56","author":"Banales","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib72","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/hep.21042","article-title":"Bicarbonate-rich choleresis induced by secretin in normal rat is taurocholate-dependent and involves AE2 anion exchanger","volume":"43","author":"Banales","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib73","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1053\/jhep.2002.33634","article-title":"Defective regulation of cholangiocyte Cl-\/HCO3(-) and Na+\/H+ exchanger activities in primary biliary cirrhosis","volume":"35","author":"Melero","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib74","doi-asserted-by":"crossref","first-page":"10269","DOI":"10.1096\/fj.201802606R","article-title":"Secretin\/secretin receptor signaling mediates biliary damage and liver fibrosis in early-stage primary biliary cholangitis","volume":"33","author":"Kennedy","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.cld.2022.06.003_bib75","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/hep.28550","article-title":"Soluble adenylyl cyclase regulates bile salt-induced apoptosis in human cholangiocytes","volume":"64","author":"Chang","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib76","first-page":"695","article-title":"Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cells","volume":"118","author":"Arenas","year":"2008","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cld.2022.06.003_bib77","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jhep.2018.08.020","article-title":"Primary biliary cholangitis: a tale of epigenetically-induced secretory failure?","volume":"69","author":"Rodrigues","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2022.06.003_bib78","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jceh.2021.08.017","article-title":"A\u00a0current understanding of bile acids in chronic liver disease","volume":"12","author":"Farooqui","year":"2022","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.cld.2022.06.003_bib79","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1053\/j.gastro.2008.02.020","article-title":"Ae2a,b-deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis","volume":"134","author":"Salas","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2022.06.003_bib80","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jcmgh.2019.04.013","article-title":"Pathophysiology of cystic fibrosis liver disease: a Channelopathy leading to alterations in innate immunity and in microbiota","volume":"8","author":"Fiorotto","year":"2019","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2022.06.003_bib81","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jhep.2021.09.042","article-title":"Cystic fibrosis-related liver disease: clinical presentations, diagnostic and monitoring approaches in the era of CFTR modulator therapies","volume":"76","author":"Dana","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2022.06.003_bib82","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev-pathol-020712-164014","article-title":"The immunobiology and pathophysiology of primary biliary cirrhosis","volume":"8","author":"Hirschfield","year":"2013","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.cld.2022.06.003_bib83","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.1840120219","article-title":"Analysis of hepatic T lymphocyte and immunoglobulin deposits in patients with primary biliary cirrhosis","volume":"12","author":"Krams","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib84","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jaut.2011.05.009","article-title":"T\u00a0cell clonal expansions detected in patients with primary biliary cirrhosis express CX3CR1","volume":"37","author":"Zhang","year":"2011","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.cld.2022.06.003_bib85","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jhep.2021.04.055","article-title":"An international genome-wide meta-analysis of primary biliary cholangitis: novel risk loci and candidate drugs","volume":"75","author":"Cordell","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2022.06.003_bib86","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jaut.2016.12.012","article-title":"Chemokine receptor CXCR3 deficiency exacerbates murine autoimmune cholangitis by promoting pathogenic CD8(+) T\u00a0cell activation","volume":"78","author":"Ma","year":"2017","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.cld.2022.06.003_bib87","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/hep.24526","article-title":"Fine phenotypic and functional characterization of effector cluster of differentiation 8 positive T\u00a0cells in human patients with primary biliary cirrhosis","volume":"54","author":"Tsuda","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib88","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1749-6632.2009.05133.x","article-title":"Th1 and Th17 cells: adversaries and collaborators","volume":"1183","author":"Damsker","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cld.2022.06.003_bib89","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1002\/hep.26979","article-title":"IL-12\/Th1 and IL-23\/Th17 biliary microenvironment in primary biliary cirrhosis: implications for therapy","volume":"59","author":"Yang","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib90","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/hep.21123","article-title":"Liver-targeted and peripheral blood alterations of regulatory T\u00a0cells in primary biliary cirrhosis","volume":"43","author":"Lan","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib91","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/cmi.2010.40","article-title":"CD4+ CD25+ but not CD4+ Foxp3+ T\u00a0cells as a regulatory subset in primary biliary cirrhosis","volume":"7","author":"Wang","year":"2010","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.cld.2022.06.003_bib92","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jaut.2018.07.020","article-title":"Increased sensitivity of Treg cells from patients with PBC to low dose IL-12 drives their differentiation into IFN-gamma secreting cells","volume":"94","author":"Liaskou","year":"2018","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.cld.2022.06.003_bib93","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/nm.2426","article-title":"Follicular regulatory T\u00a0cells expressing Foxp3 and Bcl-6 suppress germinal center reactions","volume":"17","author":"Chung","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.cld.2022.06.003_bib94","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/hep.27306","article-title":"CXCR5+ CD4+ T follicular helper cells participate in the pathogenesis of primary biliary cirrhosis","volume":"61","author":"Wang","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib95","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/hep.27552","article-title":"Follicles, germinal centers, and immune mechanisms in primary biliary cirrhosis","volume":"61","author":"Webb","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib96","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/sji.12616","article-title":"Dysregulation of circulating Tfr\/Tfh ratio in primary biliary cholangitis","volume":"86","author":"Zheng","year":"2017","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.cld.2022.06.003_bib97","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/hep4.1226","article-title":"Follicular T helper cell Signatures in primary biliary cholangitis and primary sclerosing cholangitis","volume":"2","author":"Adam","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.cld.2022.06.003_bib98","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2174\/156652409787314525","article-title":"Innate immunity and primary biliary cirrhosis","volume":"9","author":"Selmi","year":"2009","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.cld.2022.06.003_bib99","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.dld.2013.01.005","article-title":"Apotopes and innate immune system: novel players in the primary biliary cirrhosis scenario","volume":"45","author":"Lleo","year":"2013","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cld.2022.06.003_bib100","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/MOG.0000000000000814","article-title":"Macrophages in cholangiopathies","volume":"38","author":"Bruneau","year":"2022","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.cld.2022.06.003_bib101","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s10620-013-2920-6","article-title":"Chemokine-chemokine receptor CCL2-CCR2 and CX3CL1-CX3CR1 axis may play a role in the aggravated inflammation in primary biliary cirrhosis","volume":"59","author":"Sasaki","year":"2014","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cld.2022.06.003_bib102","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/ni1309","article-title":"Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2","volume":"7","author":"Serbina","year":"2006","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cld.2022.06.003_bib103","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.3389\/fimmu.2018.01852","article-title":"The critical role of chemokine (C-C motif) receptor 2-positive monocytes in autoimmune cholangitis","volume":"9","author":"Reuveni","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.cld.2022.06.003_bib104","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/hep4.1619","article-title":"Efficacy and Safety of cenicriviroc in patients with primary sclerosing cholangitis: PERSEUS study","volume":"5","author":"Eksteen","year":"2021","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.cld.2022.06.003_bib105","doi-asserted-by":"crossref","first-page":"718841","DOI":"10.3389\/fimmu.2021.718841","article-title":"Interleukin 23 produced by hepatic monocyte-derived macrophages is essential for the development of murine primary biliary cholangitis","volume":"12","author":"Reuveni","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.cld.2022.06.003_bib106","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/hep.29418","article-title":"A\u00a0functional characteristic of cysteine-rich protein 61: Modulation of myeloid-derived suppressor cells in liver inflammation","volume":"67","author":"Zhang","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib107","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jaut.2013.07.003","article-title":"The role of natural killer cells in autoimmune liver disease: a comprehensive review","volume":"46","author":"Hudspeth","year":"2013","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.cld.2022.06.003_bib108","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/hep.24194","article-title":"Interaction between Toll-like receptors and natural killer cells in the destruction of bile ducts in primary biliary cirrhosis","volume":"53","author":"Shimoda","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib109","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/hep.28122","article-title":"Natural killer cells regulate T\u00a0cell immune responses in primary biliary cirrhosis","volume":"62","author":"Shimoda","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib110","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02633","article-title":"Constitutive activation of natural killer cells in primary biliary cholangitis","volume":"10","author":"Hydes","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.cld.2022.06.003_bib111","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/nature01433","article-title":"Selection of evolutionarily conserved mucosal-associated invariant T\u00a0cells by MR1","volume":"422","author":"Treiner","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.cld.2022.06.003_bib112","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/eji.201343509","article-title":"CD161++ CD8+ T\u00a0cells, including the MAIT cell subset, are specifically activated by IL-12+IL-18 in a TCR-independent manner","volume":"44","author":"Ussher","year":"2014","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cld.2022.06.003_bib113","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.jhep.2016.02.003","article-title":"Lights on MAIT cells, a new immune player in liver diseases","volume":"64","author":"Toubal","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2022.06.003_bib114","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/jgh.14076","article-title":"Persistent reduction of mucosal-associated invariant T\u00a0cells in primary biliary cholangitis","volume":"33","author":"Setsu","year":"2018","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2022.06.003_bib115","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jaut.2018.01.007","article-title":"The immunobiology of mucosal-associated invariant T\u00a0cell (MAIT) function in primary biliary cholangitis: regulation by cholic acid-induced Interleukin-7","volume":"90","author":"Jiang","year":"2018","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.cld.2022.06.003_bib116","doi-asserted-by":"crossref","first-page":"578548","DOI":"10.3389\/fimmu.2021.578548","article-title":"CXCL12-CXCR4-Mediated chemotaxis supports accumulation of mucosal-associated invariant T\u00a0cells into the liver of patients with PBC","volume":"12","author":"Chen","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.cld.2022.06.003_bib117","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.3748\/wjg.v27.i25.3705","article-title":"Incorporating mucosal-associated invariant T\u00a0cells into the pathogenesis of chronic liver disease","volume":"27","author":"Czaja","year":"2021","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cld.2022.06.003_bib118","doi-asserted-by":"crossref","DOI":"10.1002\/hep.32405","article-title":"Mechanisms & Molecules: what are the treatment targets for PBC?","author":"Mayo","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib119","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1053\/j.gastro.2004.05.005","article-title":"Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment","volume":"127","author":"Selmi","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2022.06.003_bib120","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/hep.29675","article-title":"Using the Icelandic genealogical database to define the familial risk of primary biliary cholangitis","volume":"68","author":"Ornolfsson","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib121","doi-asserted-by":"crossref","first-page":"104292","DOI":"10.1016\/j.ejmg.2021.104292","article-title":"The genetic architecture of primary biliary cholangitis","volume":"64","author":"Gerussi","year":"2021","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.cld.2022.06.003_bib122","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1056\/NEJMoa0810440","article-title":"Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants","volume":"360","author":"Hirschfield","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2022.06.003_bib123","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/ng.631","article-title":"Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis","volume":"42","author":"Hirschfield","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.cld.2022.06.003_bib124","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/ng.627","article-title":"Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis","volume":"42","author":"Liu","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.cld.2022.06.003_bib125","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ng.789","article-title":"Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis","volume":"43","author":"Mells","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.cld.2022.06.003_bib126","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/ng.2395","article-title":"Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis","volume":"44","author":"Liu","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.cld.2022.06.003_bib127","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ajhg.2012.08.010","article-title":"Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population","volume":"91","author":"Nakamura","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cld.2022.06.003_bib128","doi-asserted-by":"crossref","first-page":"14828","DOI":"10.1038\/ncomms14828","article-title":"A\u00a0genome-wide association study identifies six novel risk loci for primary biliary cholangitis","volume":"8","author":"Qiu","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.cld.2022.06.003_bib129","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.1093\/hmg\/dds359","article-title":"Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants","volume":"21","author":"Juran","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cld.2022.06.003_bib130","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/hep.23132","article-title":"Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II mice","volume":"50","author":"Yoshida","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib131","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/hep.28641","article-title":"Chronic expression of interferon-gamma leads to murine autoimmune cholangitis with a female predominance","volume":"64","author":"Bae","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib132","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/hep.28359","article-title":"Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: a proof-of-concept study","volume":"64","author":"Hirschfield","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib133","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/hep.26067","article-title":"Therapeutic effect of cytotoxic T lymphocyte antigen 4\/immunoglobulin on a murine model of primary biliary cirrhosis","volume":"57","author":"Dhirapong","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib134","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jaut.2019.04.005","article-title":"Therapeutic trials of biologics in primary biliary cholangitis: an open label study of abatacept and review of the literature","volume":"101","author":"Bowlus","year":"2019","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.cld.2022.06.003_bib135","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.ajhg.2013.03.017","article-title":"eXclusion: toward integrating the X chromosome in genome-wide association analyses","volume":"92","author":"Wise","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cld.2022.06.003_bib136","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1053\/j.gastro.2021.02.061","article-title":"Chromosome contribution to the genetic architecture of primary biliary cholangitis","volume":"160","author":"Asselta","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2022.06.003_bib137","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/hep.22651","article-title":"Deficiency in regulatory T\u00a0cells results in development of antimitochondrial antibodies and autoimmune cholangitis","volume":"49","author":"Zhang","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib138","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/cei.12415","article-title":"Successful immunotherapy of autoimmune cholangitis by adoptive transfer of forkhead box protein 3(+) regulatory T\u00a0cells","volume":"178","author":"Tanaka","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cld.2022.06.003_bib139","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1055\/s-0034-1383726","article-title":"Environmental factors in primary biliary cirrhosis","volume":"34","author":"Juran","year":"2014","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cld.2022.06.003_bib140","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41575-019-0226-7","article-title":"Primary biliary cholangitis: pathogenesis and therapeutic opportunities","volume":"17","author":"Gulamhusein","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2022.06.003_bib141","first-page":"127","article-title":"Molecular mimicry as a mechanism for the cause and a probe uncovering etiologic agent(s) of autoimmune disease","volume":"145","author":"Oldstone","year":"1989","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.cld.2022.06.003_bib142","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0016-5085(03)00387-1","article-title":"Molecular mimicry of mitochondrial and nuclear autoantigens in primary biliary cirrhosis","volume":"124","author":"Shimoda","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2022.06.003_bib143","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hep.20907","article-title":"Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients","volume":"42","author":"Gershwin","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib144","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1053\/jhep.2003.50446","article-title":"Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium","volume":"38","author":"Selmi","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib145","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1084\/jem.181.5.1835","article-title":"HLA DRB4 0101-restricted immunodominant T\u00a0cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases","volume":"181","author":"Shimoda","year":"1995","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.cld.2022.06.003_bib146","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/hep.21076","article-title":"Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites","volume":"43","author":"Ala","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib147","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/aje\/kwt308","article-title":"No rise in incidence but geographical heterogeneity in the occurrence of primary biliary cirrhosis in North East England","volume":"179","author":"McNally","year":"2014","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.cld.2022.06.003_bib148","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jhep.2010.02.019","article-title":"Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis","volume":"53","author":"Corpechot","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2022.06.003_bib149","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00535-021-01836-6","article-title":"Environmental factors, medical and family history, and comorbidities associated with primary biliary cholangitis in Japan: a multicenter case-control study","volume":"57","author":"Matsumoto","year":"2022","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.cld.2022.06.003_bib150","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3748\/wjg.v22.i1.338","article-title":"Xenobiotics and loss of tolerance in primary biliary cholangitis","volume":"22","author":"Wang","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cld.2022.06.003_bib151","doi-asserted-by":"crossref","first-page":"5874","DOI":"10.4049\/jimmunol.174.9.5874","article-title":"Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid","volume":"174","author":"Amano","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.cld.2022.06.003_bib152","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/hep.29059","article-title":"The fingerprint of antimitochondrial antibodies and the etiology of primary biliary cholangitis","volume":"65","author":"Shuai","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib153","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/hep.22390","article-title":"Loss of tolerance in C57BL\/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease","volume":"48","author":"Wakabayashi","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib154","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2006.06.002","article-title":"Identification of 2-nonynoic acid, a cosmetic component, as a potential trigger of primary biliary cirrhosis","volume":"27","author":"Rieger","year":"2006","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.cld.2022.06.003_bib155","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jaut.2011.06.001","article-title":"Electrophile-modified lipoic derivatives of PDC-E2 elicits anti-mitochondrial antibody reactivity","volume":"37","author":"Naiyanetr","year":"2011","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.cld.2022.06.003_bib156","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.molmed.2012.07.005","article-title":"Xenobiotics and autoimmunity: does acetaminophen cause primary biliary cirrhosis?","volume":"18","author":"Leung","year":"2012","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.cld.2022.06.003_bib157","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jhep.2018.06.027","article-title":"Identification of a xenobiotic as a potential environmental trigger in primary biliary cholangitis","volume":"69","author":"Probert","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2022.06.003_bib158","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1056\/NEJMra1600266","article-title":"The human intestinal microbiome in Health and disease","volume":"375","author":"Lynch","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2022.06.003_bib159","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.molmed.2020.04.001","article-title":"The gut microbiota: emerging evidence in autoimmune diseases","volume":"26","author":"Zhang","year":"2020","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.cld.2022.06.003_bib160","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41423-020-00592-6","article-title":"Gut microbiome, liver immunology, and liver diseases","volume":"18","author":"Wang","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.cld.2022.06.003_bib161","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/0016-5085(88)90442-8","article-title":"Treatment of pruritus in primary biliary cirrhosis with rifampin. Results of a double-blind, crossover, randomized trial","volume":"94","author":"Ghent","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2022.06.003_bib162","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/0016-5085(92)90335-V","article-title":"Effects of long-term rifampicin administration in primary biliary cirrhosis","volume":"102","author":"Bachs","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2022.06.003_bib163","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1111\/1462-2920.13401","article-title":"Alterations and correlations of the gut microbiome, metabolism and immunity in patients with primary biliary cirrhosis","volume":"18","author":"Lv","year":"2016","journal-title":"Environ Microbiol"},{"key":"10.1016\/j.cld.2022.06.003_bib164","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/gutjnl-2016-313332","article-title":"Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy","volume":"67","author":"Tang","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.cld.2022.06.003_bib165","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12016-019-08731-2","article-title":"Comprehensive analysis of serum and fecal bile acid profiles and interaction with gut microbiota in primary biliary cholangitis","volume":"58","author":"Chen","year":"2020","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.cld.2022.06.003_bib166","doi-asserted-by":"crossref","first-page":"1946366","DOI":"10.1080\/19490976.2021.1946366","article-title":"Alterations in microbiota and their metabolites are associated with beneficial effects of bile acid sequestrant on icteric primary biliary Cholangitis","volume":"13","author":"Li","year":"2021","journal-title":"Gut Microbes"},{"key":"10.1016\/j.cld.2022.06.003_bib167","doi-asserted-by":"crossref","first-page":"19705","DOI":"10.1038\/s41598-021-99314-9","article-title":"Ileal mucosa-associated microbiota overgrowth associated with pathogenesis of primary biliary cholangitis","volume":"11","author":"Kitahata","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.cld.2022.06.003_bib168","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/hepr.13509","article-title":"Gut dysbiosis associated with clinical prognosis of patients with primary biliary cholangitis","volume":"50","author":"Furukawa","year":"2020","journal-title":"Hepatol Res"},{"key":"10.1016\/j.cld.2022.06.003_bib169","first-page":"368","article-title":"Short-chain fatty acid and fecal microbiota profiles are linked to fibrosis in primary biliary cholangitis","author":"Lammert","year":"2021","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.cld.2022.06.003_bib170","doi-asserted-by":"crossref","first-page":"e13714","DOI":"10.1111\/eci.13714","article-title":"Alterations in gut microbiota and elevated serum bilirubin in primary biliary cholangitis patients treated with ursodeoxycholic acid","volume":"52","author":"Han","year":"2022","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.cld.2022.06.003_bib171","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jhep.2016.09.020","article-title":"The gut microbiota contributes to a mouse model of spontaneous bile duct inflammation","volume":"66","author":"Schrumpf","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2022.06.003_bib172","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/JLB.3MA0321-037R","article-title":"Gut microbiota contributes to sexual dimorphism in murine autoimmune cholangitis","volume":"110","author":"Huang","year":"2021","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.cld.2022.06.003_bib173","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41579-020-0367-2","article-title":"Host-microbiota interactions in immune-mediated diseases","volume":"18","author":"Ruff","year":"2020","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.cld.2022.06.003_bib174","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1053\/j.gastro.2020.04.077","article-title":"Contribution of the intestinal microbiome and gut barrier to hepatic disorders","volume":"159","author":"Chopyk","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2022.06.003_bib175","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41575-018-0011-z","article-title":"The gut-liver axis and the intersection with the microbiome","volume":"15","author":"Tripathi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2022.06.003_bib176","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1194\/jlr.R054114","article-title":"Intestinal transport and metabolism of bile acids","volume":"56","author":"Dawson","year":"2015","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.cld.2022.06.003_bib177","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1136\/gutjnl-2016-312729","article-title":"Gut microbiome and liver diseases","volume":"65","author":"Tilg","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.cld.2022.06.003_bib178","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.bbadis.2017.07.024","article-title":"Role of inflammation and proinflammatory cytokines in cholangiocyte pathophysiology","volume":"1864","author":"Pinto","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.cld.2022.06.003_bib179","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.bbadis.2017.08.019","article-title":"How the biliary tree maintains immune tolerance?","volume":"1864","author":"Zhang","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.cld.2022.06.003_bib180","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrgastro.2015.200","article-title":"Immunology in the liver--from homeostasis to disease","volume":"13","author":"Heymann","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2022.06.003_bib181","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1126\/science.aat0835","article-title":"Intestinal barriers protect against disease","volume":"359","author":"Citi","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.cld.2022.06.003_bib182","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1126\/science.aar7201","article-title":"Translocation of a gut pathobiont drives autoimmunity in mice and humans","volume":"359","author":"Manfredo Vieira","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.cld.2022.06.003_bib183","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1136\/gutjnl-2020-320786","article-title":"Targeting the gut-liver-immune axis to treat cirrhosis","volume":"70","author":"Tranah","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.cld.2022.06.003_bib184","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/cmi.2018.7","article-title":"The microbiome and autoimmunity: a paradigm from the gut-liver axis","volume":"15","author":"Li","year":"2018","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.cld.2022.06.003_bib185","doi-asserted-by":"crossref","DOI":"10.1007\/s00281-022-00917-9","article-title":"Th17 cells in the liver: balancing autoimmunity and pathogen defense","author":"Taniki","year":"2022","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.cld.2022.06.003_bib186","doi-asserted-by":"crossref","first-page":"711217","DOI":"10.3389\/fimmu.2021.711217","article-title":"Gut-liver immune traffic: Deciphering immune-pathogenesis to Underpin translational therapy","volume":"12","author":"Bozward","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.cld.2022.06.003_bib187","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.autrev.2017.07.002","article-title":"Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases","volume":"16","author":"Li","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.cld.2022.06.003_bib188","doi-asserted-by":"crossref","DOI":"10.3390\/cells9030736","article-title":"Gut-liver Axis and inflammasome activation in cholangiocyte pathophysiology","volume":"9","author":"Maroni","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.cld.2022.06.003_bib189","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19103003","article-title":"Inflammation and the gut-liver Axis in the pathophysiology of cholangiopathies","volume":"19","author":"Giordano","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cld.2022.06.003_bib190","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/MOG.0000000000000807","article-title":"The gut-liver axis in cholangiopathies: focus on bile acid based pharmacological treatment","volume":"38","author":"Cariello","year":"2022","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.cld.2022.06.003_bib191","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1111\/liv.13143","article-title":"Low incidence of primary biliary cirrhosis (PBC) in the first-degree relatives of PBC probands after 8 years of follow-up","volume":"36","author":"Gulamhusein","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2022.06.003_bib192","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jaut.2018.10.015","article-title":"The immunobiology of female predominance in primary biliary cholangitis","volume":"95","author":"Gerussi","year":"2018","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.cld.2022.06.003_bib193","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(04)15541-4","article-title":"Frequency of monosomy X in women with primary biliary cirrhosis","volume":"363","author":"Invernizzi","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2022.06.003_bib194","doi-asserted-by":"crossref","first-page":"575","DOI":"10.4049\/jimmunol.175.1.575","article-title":"X\u00a0chromosome monosomy: a common mechanism for autoimmune diseases","volume":"175","author":"Invernizzi","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.cld.2022.06.003_bib195","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nri2815","article-title":"The X chromosome in immune functions: when a chromosome makes the difference","volume":"10","author":"Libert","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cld.2022.06.003_bib196","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/hep.21696","article-title":"Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis","volume":"46","author":"Miozzo","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib197","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.autrev.2004.05.003","article-title":"Primary biliary cirrhosis: does X mark the spot?","volume":"3","author":"Selmi","year":"2004","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.cld.2022.06.003_bib198","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaut.2009.03.003","article-title":"X-linked primary immunodeficiencies as a bridge to better understanding X-chromosome related autoimmunity","volume":"33","author":"Pessach","year":"2009","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.cld.2022.06.003_bib199","first-page":"128","article-title":"Genome-wide analysis of DNA methylation, copy number variation, and gene expression in monozygotic twins discordant for primary biliary cirrhosis","volume":"5","author":"Selmi","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.cld.2022.06.003_bib200","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1600-065X.2009.00782.x","article-title":"Molecular mechanism and function of CD40\/CD40L engagement in the immune system","volume":"229","author":"Elgueta","year":"2009","journal-title":"Immunol Rev"},{"key":"10.1016\/j.cld.2022.06.003_bib201","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1196\/annals.1361.062","article-title":"Soluble CD40L in plasma of patients with primary biliary cirrhosis","volume":"1051","author":"Oertelt","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cld.2022.06.003_bib202","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1478-3231.2005.01211.x","article-title":"The relationship between hepatic immunoglobulin production and CD154 expression in chronic liver diseases","volume":"26","author":"Mayo","year":"2006","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2022.06.003_bib203","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/hep.24630","article-title":"Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosis","volume":"55","author":"Lleo","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib204","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13148-015-0098-9","article-title":"DNA methylation profiling of the X chromosome reveals an aberrant demethylation on CXCR3 promoter in primary biliary cirrhosis","volume":"7","author":"Lleo","year":"2015","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.cld.2022.06.003_bib205","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jaut.2005.08.009","article-title":"Increased levels of chemokine receptor CXCR3 and chemokines IP-10 and MIG in patients with primary biliary cirrhosis and their first degree relatives","volume":"25","author":"Chuang","year":"2005","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.cld.2022.06.003_bib206","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/hep.29653","article-title":"MicroRevolution in understanding primary biliary cholangitis pathophysiology","volume":"67","author":"Afonso","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib207","doi-asserted-by":"crossref","first-page":"J187","DOI":"10.1016\/j.jaut.2011.11.012","article-title":"The X chromosome and immune associated genes","volume":"38","author":"Bianchi","year":"2012","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.cld.2022.06.003_bib208","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/hep.29533","article-title":"MicroRNA-506 promotes primary biliary cholangitis-like features in cholangiocytes and immune activation","volume":"67","author":"Erice","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib209","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1074\/jbc.M114.587030","article-title":"Post-translational regulation of the type III inositol 1,4,5-trisphosphate receptor by miRNA-506","volume":"290","author":"Ananthanarayanan","year":"2015","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.cld.2022.06.003_bib210","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0016-5085(03)01201-0","article-title":"Loss of inositol 1,4,5-trisphosphate receptors from bile duct epithelia is a common event in cholestasis","volume":"125","author":"Shibao","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2022.06.003_bib211","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/hep.29603","article-title":"Genetic association studies and the risk factors for developing the \"Immuno-bile-logic\" disease primary biliary cholangitis","volume":"67","author":"Liaskou","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.06.003_bib212","doi-asserted-by":"crossref","first-page":"e0198757","DOI":"10.1371\/journal.pone.0198757","article-title":"Dysbiosis of oral microbiota and its association with salivary immunological biomarkers in autoimmune liver disease","volume":"13","author":"Abe","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.cld.2022.06.003_bib213","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/liv.14069","article-title":"Autotaxin, bile acid profile and effect of ileal bile acid transporter inhibition in primary biliary cholangitis patients with pruritus","volume":"39","author":"Hegade","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2022.06.003_bib214","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/apt.15754","article-title":"A\u00a0disease-specific decline of the relative abundance of Bifidobacterium in patients with autoimmune hepatitis","volume":"51","author":"Liwinski","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2022.06.003_bib215","doi-asserted-by":"crossref","first-page":"713647","DOI":"10.3389\/fimmu.2021.713647","article-title":"The salivary microbiota of patients with primary biliary cholangitis is Distinctive and pathogenic","volume":"12","author":"Lv","year":"2021","journal-title":"Front Immunol"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326122000411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326122000411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:58:35Z","timestamp":1761069515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326122000411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":215,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S1089326122000411"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2022.06.003","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunologic Responses and the Pathophysiology of Primary Biliary Cholangitis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2022.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}